Three DNA methylation epigenotypes in human colorectal cancer.
about
Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature ReviewMolecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseMolecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary fieldDifferent definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic reviewCpG Island Methylator Phenotype-High Colorectal Cancers and Their Prognostic Implications and Relationships with the Serrated Neoplasia PathwayEmerging technologies for studying DNA methylation for the molecular diagnosis of cancerWhole-genome methylation analysis of benign and malignant colorectal tumoursA KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotypeDifferences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancerThe BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotypeAssessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectumEpigenetic Biomarkers in Colorectal Cancer.Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiencyA genome-wide DNA methylation study in colorectal carcinoma.Methylcap-seq reveals novel DNA methylation markers for the diagnosis and recurrence prediction of bladder cancer in a Chinese population.Keratin23 (KRT23) knockdown decreases proliferation and affects the DNA damage response of colon cancer cellsGenetic and Epigenetic Intra-tumour Heterogeneity in Colorectal CancerThe CpG island methylator phenotype (CIMP) in colorectal cancer.DNA methylation epigenotype and clinical features of NRAS-mutation(+) colorectal cancerArray-based DNA methylation profiling for breast cancer subtype discrimination.Extramural vascular invasion and response to neoadjuvant chemoradiotherapy in rectal cancer: Influence of the CpG island methylator phenotype.Early detection of gastric cancer using global, genome-wide and IRF4, ELMO1, CLIP4 and MSC DNA methylation in endoscopic biopsiesDistinct molecular features of different macroscopic subtypes of colorectal neoplasmsAssessment of three epigenotypes in colorectal cancer by combined bisulfite restriction analysis.DNA methylation profiling of embryonic stem cell differentiation into the three germ layersActivation of Bmp2-Smad1 signal and its regulation by coordinated alteration of H3K27 trimethylation in Ras-induced senescence.Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas.Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenomaGene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X.Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancerIdentification of new differentially methylated genes that have potential functional consequences in prostate cancer.Curcumin modulates DNA methylation in colorectal cancer cells.Identifying and validating a combined mRNA and microRNA signature in response to imatinib treatment in a chronic myeloid leukemia cell line.STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancersDistinct profiles of epigenetic evolution between colorectal cancers with and without metastasis.Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patientsPrognostic value of KRAS and BRAF mutations in curatively resected colorectal cancerDiagnostic and prognostic utility of a DNA hypermethylated gene signature in prostate cancer.Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer.
P2860
Q24289005-E6E65A44-BD23-4007-9B0D-2EC3FEC5FC57Q24289344-6697AE6F-0A79-49E0-91FA-18FF9AB6D3DDQ24620628-52DBD102-5D97-4230-A5BA-C18BD51E8CC3Q26768471-A9F77874-BB30-4DC6-89CB-4B1DFFB4727FQ28066004-DCBF1610-6B4A-4EA4-B1DF-0FAFD16C088BQ28087759-0E07ECC7-55D9-40D3-9067-52756BF8D07DQ28109367-DEB9D188-DCEA-4BF3-ADE3-255010015ED6Q28117127-B9B7C4C6-F832-48DD-9C74-3C99D60F592EQ28239338-FC5F021D-06F8-49A9-BAD7-0DE8407182B0Q28247866-C97678CA-6845-483D-A2DB-236A7922E458Q28262150-DDDDE51D-34AA-43E7-97F1-E29F08E8BF78Q30240778-E542DB70-DBAB-4401-8158-412BC23E29CEQ30465158-A67D0523-2905-428F-BBEA-D4468921D3DFQ31020320-8BD6E2DE-5461-4F54-8FCB-0BD70503C164Q31058055-2E37EDCA-0580-489E-BC25-417C3C3E3F72Q31139458-DFF952F3-4A33-4336-94B1-1DD5C0F12222Q33571591-281A93D0-D052-4269-8DEA-3BB020E9DB1FQ33596629-2EA21705-02C2-465F-B677-AECCDDA69911Q33679684-B7A33FD9-2B3F-4C4B-87ED-DDA72C73DE86Q33689442-D1789FB6-A1FD-446F-A7F1-2FE655188FC3Q33696207-35B3C8A5-742F-4CA3-92F7-4454C8E9D513Q33888849-FED4D447-CD9E-4E69-BBF2-41977502AAEEQ34004693-AD0DCD85-C0EE-465C-89F2-DA4A1E2F7FF9Q34050217-1A9A38D1-8FDB-4FC2-A6CC-7527D2B3B618Q34053462-F91C306F-5F35-4ACE-9B35-AA68D63D3E4CQ34071417-85E35678-3AB1-4785-809F-30FB333168C3Q34170505-339FE784-0E7E-48FE-B594-69C6570699EAQ34181789-6FABBDED-F6E5-45C8-848B-6DB18DA2E704Q34254446-4F0449B4-8F96-40A3-B95F-62559597CC69Q34269998-E2FDD4C9-B9E7-4036-A7BC-A46EBCF0BC60Q34358286-67D54E35-60FA-46B9-A48B-04FE031B8054Q34465132-18176DAC-69E1-4963-90C5-58E25389F9AFQ34608782-B0B5CB24-DB42-4026-95B6-2B0267792C7CQ34703835-8A2A915E-D181-4CC8-A411-C6444F3462D6Q34796500-F31E5028-4F15-461B-88EB-F040B7AA44E4Q34805590-3A638D05-5333-4AA5-A463-85100EE30496Q34998496-1627E1C0-B9E9-429A-9508-A2D9CD2AA4C3Q35012132-94C4A01C-7082-4356-9FE3-8168BA983018Q35120213-8AA2DA74-60DD-4F04-BD15-5769A5145401Q35138892-759FA4F2-D574-4C6F-874D-0B5ADE11CBB4
P2860
Three DNA methylation epigenotypes in human colorectal cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Three DNA methylation epigenotypes in human colorectal cancer.
@ast
Three DNA methylation epigenotypes in human colorectal cancer.
@en
Three DNA methylation epigenotypes in human colorectal cancer.
@nl
type
label
Three DNA methylation epigenotypes in human colorectal cancer.
@ast
Three DNA methylation epigenotypes in human colorectal cancer.
@en
Three DNA methylation epigenotypes in human colorectal cancer.
@nl
prefLabel
Three DNA methylation epigenotypes in human colorectal cancer.
@ast
Three DNA methylation epigenotypes in human colorectal cancer.
@en
Three DNA methylation epigenotypes in human colorectal cancer.
@nl
P2093
P1476
Three DNA methylation epigenotypes in human colorectal cancer.
@en
P2093
Atsushi Kaneda
Genta Nagae
Hirohiko Sakamoto
Hiroshi Hayashi
Hiroyuki Aburatani
Kiwamu Akagi
Koichi Yagi
Shingo Tsuji
Takayuki Isagawa
Yasuyuki Seto
P356
10.1158/1078-0432.CCR-09-2006
P407
P577
2009-12-22T00:00:00Z